Research Interests
Research Interests
Dr. Doloff’s lab in Immunoengineering and Regenerative Medicine is interested in systems biology for understanding tissue dynamics pertaining to immunologic engagement, with applications in biomaterial/biomedical devices, controlled drug delivery systems, and synthetic cellular engineering. Specific emphasis will be applied toward engineering improved therapies in the fields of cancer, autoimmunity and transplantation medicine (i.e. type 1 diabetes), and ophthalmology.
Titles & Affiliations
Titles
- Associate Professor, Biomedical Engineering
- Associate Professor, Materials Science & Engineering
- Associate Professor, Oncology (Cancer Immunology)
Affiliated Centers & Institutes
Education
Education
- Postdoctoral Fellowship, Langer/Anderson Labs, Koch Institute, MIT, 2011-2018
- PhD, Molecular, Cellular Biology & Biochemistry, Boston University, 2011
- MA, Molecular, Cellular Biology & Biochemistry, Boston University, 2011
- BSE, Bioengineering, University of Pennsylvania, 2004
Faculty News
Recent Highlights
-
March 18, 2025Biomedical engineer Joshua Doloff uses federal funding to pioneer immunotherapies that could free diabetes patients from insulin dependence.
-
June 24, 2024Each honoree will each receive a $75,000 grant to support their work over the next year. They also will have the opportunity to participate in mentoring sessions and events designed to connect them with colleagues at similar stages in their careers.
-
April 3, 2024Doloff will use funds to expand research in developing strategies for precise ovarian cancer treatment.